These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2142806

  • 21. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
    Honda M, Satoh M, Tujimoto Y, Takada T, Matsumiya K, Fujioka H.
    Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
    [Abstract] [Full Text] [Related]

  • 22. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
    Campo B, Torelli T, Leidi GL, Corrada P, Bacchioni AM, Ordesi G, Zanitzer L.
    Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
    [Abstract] [Full Text] [Related]

  • 23. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
    Miyanaga N, Akaza H.
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
    [Abstract] [Full Text] [Related]

  • 24. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
    Bajorin DF.
    J Clin Oncol; 2001 Sep 15; 19(18 Suppl):17S-20S. PubMed ID: 11560966
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
    Chrétien Y, Mejean A, Durdux C, Dufour B, Housset M.
    J Urol (Paris); 1996 Sep 15; 102(1):3-8. PubMed ID: 8763598
    [Abstract] [Full Text] [Related]

  • 27. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A, Pinar B, Arellano R, López M, Marín A, Jiménez U, Pérez Torrubia A.
    Arch Esp Urol; 1997 Jun 15; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [Abstract] [Full Text] [Related]

  • 28. [Preliminary clinical evaluation of systemic chemotherapy of invasive cancer of the bladder by the CMV protocol].
    Szymanowski J, Koźmińska E, Malewski A, Stokłosa A.
    Pol Tyg Lek; 1997 Jun 15; 47(24-26):525-7. PubMed ID: 1282711
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].
    Bellmunt Molins J, Ribas A, Albanell J, Lorente Garín JA, de Torres Mateos JA, Morote Robles J, López Palacios MA, Banús Gassol JM, Casado Cobo S, Eres N, Solé Calvo LA.
    Arch Esp Urol; 1996 Jun 15; 49(5):465-72. PubMed ID: 8766083
    [Abstract] [Full Text] [Related]

  • 31. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec 15; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 32. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
    Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S.
    J Urol; 2005 Jul 15; 174(1):80-5. PubMed ID: 15947583
    [Abstract] [Full Text] [Related]

  • 33. [Stage T4 bladder cancer. Impact of neoadjuvant chemotherapy on T4b tumors].
    Solsona E, Iborra I, Ricós JV, Monrós JL, Dumont R, Guillem V.
    Arch Esp Urol; 1990 Jul 15; 43 Suppl 2():205-8. PubMed ID: 2096780
    [Abstract] [Full Text] [Related]

  • 34. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T, Sakaguchi H, Kajikawa H, Nishioka T.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [Abstract] [Full Text] [Related]

  • 35. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
    Chechile G, Montie J, Pontes JE, Bukowski RM.
    Prog Clin Biol Res; 1990 Mar 15; 353():153-61. PubMed ID: 2217413
    [No Abstract] [Full Text] [Related]

  • 36. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Herr HW.
    Eur Urol; 2008 Jul 15; 54(1):126-32. PubMed ID: 18248875
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
    Qureshi KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Hall RR, Lunec J, Neal DE.
    Clin Cancer Res; 1999 Nov 15; 5(11):3500-7. PubMed ID: 10589764
    [Abstract] [Full Text] [Related]

  • 39. Neoadjuvant treatment of cancer of the bladder with M-VAC/M-VEC, and bladder-sparing policy: preliminary report of a non-randomized study.
    Galante E, Ferroni C, Bianchi S, Megale C, Molinaro S, Maymone S.
    J Exp Ther Oncol; 1996 Jul 15; 1(4):237-41. PubMed ID: 9414410
    [Abstract] [Full Text] [Related]

  • 40. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
    Millikan R, Dinney C, Swanson D, Sweeney P, Ro JY, Smith TL, Williams D, Logothetis C.
    J Clin Oncol; 2001 Oct 15; 19(20):4005-13. PubMed ID: 11600601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.